Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Affected HIMS Investor Summary Who:…
/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit…
Hims & Hers lists tirzepatide (Zepbound/Mounjaro) among its offerings, but checkout pricing for compounded or branded tirzepatide was not captured…
New class action for Hims & Hers (HIMS) urges investors to seek recovery for alleged securities fraud violations – lead…
Hims & Hers Systems Shareholders Between August 4, 2025 and July 29, 2026 - Contact Bernstein Liebhard For More Information…
LOS ANGELES, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Hims & Hers Health, Inc., (“Hims…
Comprehensive analysis of Hims & Hers Tokenized bStocks price dynamics, quarterly returns, and annual trends in dollars. Our detailed research…
Historical data tab for Hims & Hers Tokenized bStocks in USD for download and research…
Discover 1 Best Exchanges Offering 1 HIMSB Markets for Buying, Selling, and Trading Hims & Hers Tokenized bStocks. Get insights…
/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit…
Hims & Hers Health (HIMS) reported earnings 30 days ago. Whats next for the stock? We take a look at…
Regulatory Pressures Mount: Recent social media chatter highlights concerns over potential FDA actions on compounded medications and an ongoing FTC…
Hims & Hers Health is facing a class action in the Northern District of California after the FTC sued over…
Hims & Hers Health (HIMS) Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit...…
NEW YORK, NY - September 8, 2026 (NEWMEDIAWIRE) - Kaplan Fox (2) the Company charges consumers for prescriptions almost…
Kaplan Fox Continues to Alert Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to a Class Action Deadline on…
The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $28.17, representing a +1.66% change from its…
Hims & Hers stock: growth momentum versus margin pressure and a 20.6% fair value discount…
Hims & Hers stock: growth momentum versus margin pressure and a 20.6% fair value discount…
/PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud…
Hims & Hers Systems Shareholders Between August 4, 2025 and July 29, 2026 - Contact Bernstein Liebhard For More Information…
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine…
Hims & Hers Health trades at $27.71 today, down 0.4%. Regulatory risks and legal action weigh on shares amid volatile…
/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit…
Hims & Hers requires $1,194 upfront for six months of compounded semaglutide. PlexusDx offers month-to-month semaglutide at $189 with no…
New class action for Hims & Hers (HIMS) urges investors to seek recovery for alleged securities fraud violations – lead…
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential…
Hims & Hers trades at $27.71 today, down 0.4%. Get the latest on HIMS price action, technicals, and trading range…
/PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has…
INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit…
Did you buy HIMS securities between August 4, 2025 and July 29, 2026? Affected HIMS Investor Summary Who: Hims &…
Hims & Hers Health (HIMS) is in focus after the Federal Trade Commission filed a lawsuit over its health data…
/PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health,…
Hims & Hers trades at $27.82, down 3% today amid legal challenges and regulatory scrutiny, with bearish momentum signals.…
The San Francisco-based telehealth provider Hims & Hers Health, Inc., which built its reputation on convenience and discretion, was sued…
NEW YORK, NY - September 3, 2026 (NEWMEDIAWIRE) - Kaplan Fox (2) the Company charges consumers for prescriptions almost…
On September 03, 2026, Hims & Hers Health Inc (HIMS) shares fell 3.0% to a current price of $27.82. The…
/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit…
Hims & Hers Health slides 3.17% today to $27.77 amid technical weakness and ongoing selling pressure in current trading.…